The psychedelic medicine field is rapidly evolving. Thanks to modern-day research, our understanding of how psychedelic therapy can be applied to mental health is opening the door for new approaches to wellness.

Each month, we host an expert speaker who shares innovations in psychedelic medicine, best practices for safety and harm reduction, evidence-based therapeutic approaches, research findings, and tips for health professionals working in this field.

Learn how to support your clients and stay up-to-date on the most relevant opportunities for health providers. Chat and network with other attendees through the webinar chat features. We’re here to learn from each other and strengthen our ties as a community.

Join the live monthly event to hear presentations and QA with speakers. Watch the video replays and complete your CE quizzes at any time.

By enrolling in this course, you will receive email invites to join our monthly, live, online events. Live event times vary. Videos of speaker events qualifying for CE credit will be added to the course after each live webinar.

$120 for an annual subscription to all past and future CE webinars!

2021
1. Psychedelic Harm Reduction: What Every Clinician Needs to Know
   • Erica Siegal, LCSW is a professional harm reductionist, community organizer, MDMA-assisted psychotherapy researcher, and founder of NEST Harm Reduction. From her years coordinating the Zendo Project, she provides an experienced look at what it means to provide compassionate, trauma-informed care and tools for de-escalation during a crisis in her talk Psychedelic Harm Reduction: What Every Clinician Needs to Know.
   • With Erica Siegal, LCSW
   • Earn 1 CE Credit
2. Microdosing Research: The Next Frontier for Clinical Trials and Therapeutics
   • The term “microdosing” was coined by Dr. Jim Fadiman to describe taking very small doses of a psychedelic substance. Many have reported benefits of microdosing for mental health, creativity, and well being. Yet evidence from controlled clinical trials is lacking. In this introductory webinar examine the changing landscape of microdosing research, clinical trials, and the potential applications of microdosing in therapeutic practices.
   • With James Fadiman, PhD
   • Earn 1 CE Credit
   • Learning Objectives:
     At the end of this program, participants will be better able to:
     1. List the difference in effects of a microdose and a full dose of psychedelic substances.
     2. Discuss the outcomes of current microdosing research. 
     3. Describe microdosing protocols and amounts for different psychedelic substances. 
   • The esteemed Jim Fadiman, PhD, is the foremost expert on microdosing best known for his large body of psychedelic research and classic psychedelic literature such as The Psychedelic Explorer’s Guide: Safe, Therapeutic, and Sacred Journeys. His latest endeavor with Dr. Jordan Gruber, Your Symphony of Selves: Discover and Understand More of Who We Are explores the concept of personality multiplicity and the ability to work with different selves in various situations.
3. My Journey in Starting Novel Psychedelic Research at a University
   • Jessica Nielson, PhD, founder of The Psychedelic Society of Minnesota and Assistant Profesor at the University of Minnesota discusses her 10-year journey towards becoming a professional psychedelic researcher within an academic setting. In My Journey: Starting Novel Psychedelic Research at a University, Dr. Nielson discusses the challenges of navigating the terrain of psychedelic research in academia, the ethical implications of white researchers performing clinical research on indigenous plant medicines, and her thoughts on the future of psychedelic studies during the COVID pandemic.
   • With Erica Siegal, LCSW
   • Earn 1 CE Credit
4. Psychedelic Law: A Look at Emerging Legal Questions for Clinicians
   • Plant Medicine Law Group, a group of women lawyers who have crossed the threshold into psychedelic law. Join them in a discussion of Emerging Legal Questions for Clinicians to learn about the landscape of psychedelic law, upcoming changes and what that means for mental health care professionals who are currently practicing psychedelic integration or hope to provide psychedelic-assisted therapy in the future.
   • With:
     • Serena Wu, JD, BA
     • Hadas Alterman, JD, BA
     • Adriana Kertzer, JD, BA
   • Earn 1 CE Credit
5. Cultural Considerations in Psychedelic Research
   • Sara Reed, LMFT and CEO of Mind’s iHealth Solutions, a digital health company that provides evidence based and culturally responsible mental health services for underserved groups. A former study therapist on the Psilocybin-Assisted Therapy research study for Major Depression at Yale University, sub-investigator and study coordinator for the Multidisciplinary Association for Psychedelic Studies (MAPS) Phase 2 MDMA study of posttraumatic stress disorder (PTSD), and member of Chacruna’s Racial Equity and Access Committee, Sara is well versed in in the implications of psychedelic research from a multicultural perspective. Join her for an important conversation about Cultural Considerations in Psychedelic Research.
   • With Sara Reed, LMFT
   • Earn 1 CE Credit
6. Clinical Application of Ketamine-Assisted Psychotherapy Treatment
   • Wesley Ryan, MD discusses Clinical Applications of Ketamine-assisted Psychotherapy Treatment. A board certified addiction psychiatrist, Dr. Ryan works as a clinician providing ketamine-assisted psychotherapy to patients with depression and PTSD. He’ll share with us the integration of behavioral and insight-oriented psychospiritual work with the psychedelic properties of ketamine.
   • With Wesley Ryan. MD
   • Earn 1 CE Credit
7. Zendo: Psychedelic Harm Reduction, Peer Support, and Mental Health
   • Chelsea Rose Pires, MA, LMFT and Sara Gael, MA, LPCC have over 17 collective years of harm reduction and peer support expertise with MAPS Zendo Project. Chelsea, a CIIS Counseling Psychology graduate has a passion for harm reduction as a therapeutic and practical approach to drug use and abuse prevention while Sara, a Naropa University graduate, served as the Director of Harm Reduction at MAPS from 2016-2020 and serves as a therapist for MAPS MDMA-assisted therapy clinical trials. Harm reduction experts, Chelsea and Sara, both serve DanceSafe and their local communities by offering harm reduction support and education. Join them as they discuss the implications of psychedelic harm reduction and peer support on mental health in a clinical state.
   • With:
     • Chelsea Rose, MA, LMFT
     • Sara Gael, MA
   • Earn 1 CE Credit
8. Beyond the Narrow Life: A Guide for Psychedelic Integration & Existential Exploration
   • Non-ordinary states of consciousness can elicit profound questions about oneself, the universe, and our place in it. By way of the Hero’s Journey, we explore common topics that emerge during psychedelic journeys and several frameworks for integrating these experiences. Dr. Ortigo describes how psychedelic integration practices can draw from evidence-based cognitive-behavioral therapy, Jungian depth psychology, existential philosophy, compassion and mindfulness practices, comparative mythology, pop culture, film, and scientific research. The presentation is an overview of his book Beyond The Narrow Life: A Guide for Psychedelic Integration and Existential Exploration.
   • With Kile Ortigo, PhD
   • Earn 1 CE Credit
   • Learning Objectives:
     At the end of this program, participants will be better able to:
     1. Discuss how evidence-based therapies can be applied to psychedelic integration practices.
     2. Apply the hero’s journey to topics that may emerge for clients during a psychedelic experience.
   • Kile Ortigo, PhD is the founder of the Center for Existential Exploration where his work is driven by exploring personal values, spirituality, underlying emotions, and recovery from painful life experiences. A research-trained clinician, Dr. Ortigo’s expertise in personality, attachment, trauma, and care delivery models of psychotherapy have led him to a career of advancing therapeutic protocols and manuals for clinical care, and personal growth through integrating evidence-based approaches with technology for the National Center for PTSD. Dr. Ortigo additionally serves on the CE committee at Psychedelic Support. His psychedelic work is informed by the ineffable, the cosmos, the experience of awe, the nature of reality, and symbolism which has culminated in his newest book Beyond The Narrow Life: A Guide for Psychedelic Integration and Existential Exploration.
9. Substance-Assisted Conversation: A Creative Approach to Psycholytic Problem Solving
   • Join us as Carmen Ostrander, MA, RTC, MACA incorporates a framework for therapeutic conversations informed by Narrative Therapy with expressive arts practices, to re-author stuck narratives and invite non-verbal ways of engaging with charged conscious and unconscious material.
     
     The low dose end of the psychedelic spectrum provides a wealth of opportunities for clients and their therapists to collaborate creatively on the solving of problems. Low dose experiences create relational and psychological safety and confidence, encouraging novel approaches, perspectives and skill building as a foundation for more challenging psychedelic experiences clients may seek in other contexts.
     
     Carmen Ostrander, MA, RTC, MACA is a Narrative and Expressive Arts therapist and supervisor based in Vancouver, British Columbia (Coast Salish Territories). Her independent practice, Square Peg Therapy, supports artists, queer and gender diverse folks with low barrier community centred
   • With Carmen Ostrander, MA, RTC, MACA
   • Earn 1 CE Credit
2022
10. After the Ceremony: What Clinicians Need to Know About Ayahuasca Integration
    • Ayahuasca is a complex and potent plant medicine that's spreading worldwide. The experiences can generate moments of terror and bliss, and excavate unconscious material to be seen, addressed and, eventually, resolved. How can we support clients after their ayahuasca ceremony? This talk covers the common insights (and fears) that people emerge with after ceremonies, and offers specific guidance for the emotional and somatic resourcing that's often needed following what can be an intense and sometimes overwhelming experience.
      
      Integration is crucial to helping clients incorporate their unique experiences into the entire journey of their lives. Kerry Moran, MA, LPC offers expertise in maximizing the impact of integration work, sitting with clients in the shadows, and facilitating connection across cultures when working with ayahuasca.
    • With Kerry Moran, MA, LPC
    • Earn 1 CE Credit
    • Learning Objectives:
      At the end of this program, participants will be better able to:
      1. Describe the importance of utilizing integration practices with clients who have taken ayahuasca.
      2. Identify Indigenous and modern integration techniques.
    • Kerry Moran, MA, LPC is a graduate of the Counseling Psychology program at Pacifica University. Since then, she has worked in private practice as a present-centered psychotherapist, blending the wisdom of depth psychology (Jung, Hillman) with the non-dual teaching of Tibetan Buddhism and meditation.
    • Interested in an ayahuasca integration program? Integrating Ayahuasca is a 10-week online course developed by Kerry Moran to inspire and support your post-ceremony transformation. Each week you’ll receive a link to a new class packed with practical guidance, practices and exercises specifically keyed to integration.
11. Navigating the Ethics of Psychedelic Guidance Inside and Outside of the Medical Establishment
    • Join Psychedelic Support for an important discussion with bioethicist and Joseph Holcomb Adams, MA. We’ll explore how the four principles of clinical ethics (beneficence, non-maleficence, respect for autonomy, and justice) place specific ethical obligations on healthcare professionals who practice psychedelic-assisted psychotherapy.
    • With Joseph Holcomb Adama
    • Earn 1 CE Credit
12. MAPS Commercialization Process: Taking MDMA to the Clinic
    • Balancing treatment protocols, equitable access, and regulatory compliance is a primary focus for the MAPS PBC as they look towards prescription status of MDMA in 2023.
      
      Join MAPS PBC Chief of Patient Access and Head of Commercialization, Joy Sun Cooper, MBA and Chief of Staff, James Acer, BA for a presentation on balancing treatment protocols, equitable access, and regulatory compliance is a primary focus for MAPS PBC as they look towards prescription status of MDMA. We look at the road ahead and how MDMA-assisted therapy will available for healthcare providers, patients, and our healthcare system in future.
    • With:
      • Joy Sun Cooper
      • James Acer
    • Earn 1 CE Credit
13. Pollinating Community-Based Interdisciplinary Psychedelic Centers
    • Casting a net in the fast-paced landscape of psychedelics calls for clinicians to better understand the ways in which systematic business planning can create sustainable clinics and centers for decades to come.
      
      Join for a discussion with physician and psychedelic industry expert Dr. Rae St. Arnault. We’ll explore areas of strategy and expertise needed for clinicians to build strong community-based psychedelic and ketamine clinics.
    • With Rae St. Arnault, PhD
    • Earn 1 CE Credit
14. Using Psilocybin Mushrooms in Patients on Antidepressants
    • What does psilocybin-assisted therapy look like when clients enter the clinic on antidepressant medication? Common practice is to tell patients on SSRIs and other prescription drugs that they must stop taking their psychiatric medications before they can safely take psilocybin, but neither anecdotal evidence nor the scientific literature support this. Researchers and practitioners alike are eager to find effective evidence-based treatment to assist people with anxiety, depression, and other disorders that require pharmaceutical intervention.
      
      Watch a presentation with integrative mental health professional and psychedelic facilitator, Dr. Erica Zelfand. She details the interplay between antidepressant medications and psilocybin. We review the pharmacology of these substances and consider new research on how clinicians can understand and utilize modern psychedelic research to assist clients.
    • With Erica Zelfand, ND
    • Earn 1 CE Credit
    • Learning Objectives:
      At the end of this program, participants will be better able to:
      1. Describe how psilocybin and SSRIs affect neuroplasticity of the brain.
      2. Identify combinations of substances that affect serotonin syndrome.
      3. Assess the risk of taking SSRIs with psilocybin.
    • Dr. Erica Zelfand is a licensed family doctor, ketamine provider, and psychedelic facilitator. Specializing in functional medicine and integrative mental health, she is well versed in pharmaceutical, nutritional, botanical, somatic counseling-oriented, and psychedelic approaches to healing. She also teaches psychedelic facilitation at InnerTrek in Oregon.
15. Weaving Justice into the Post-Prohibition World
    • Novel ideas for psychedelic policy reform that were once mere concepts are rapidly becoming more tangible and concrete, and are starting to be introduced and implemented in cities and states across the country. What is the difference between these approaches, and is any one path to psychedelic policy better than the others? Can the approaches to policy reform be harmonized and if so, how? Evidence nor the scientific literature support this.
      
      Watch a practical and dynamic conversation with MAPS Director of Policy & Advocacy, Ismail Lourido Ali, JD. Hear about the landscape of the national psychedelic reform ecosystem and frameworks for analysis and engagement that play an important role in the future of psychedelic medicine.
    • With Ismail Lourido Ali, JD
    • Earn 1 CE Credit
16. Are Psychedelics Right for My Patient?
    • Clinical trials of MDMA- and psilocybin-assisted therapy are investigating these novel treatments for PTSD, depression, eating disorders, anxiety related to life-threatening illness, and addiction disorders. Ketamine is currently prescribed off-label for these conditions, and esketamine is FDA-approved for depression indications. As we anticipate the future of psychedelic medicine, how will clinicians decide what is the best and safest treatment for their patient?
      
      Watch a talk around the future of psychedelic medicine in clinical practice with board-certified psychiatrist, health tech entrepreneur, and inventor, Dave Rabin. He shares what’s known for safety and effectiveness for patients when it comes to utilizing psychedelic medicines such as ketamine, MDMA, and psilocybin. We look at the drug effects and safety, screening practices, and how to evaluate risk factors to ensure quality care. Earn 1 CE credit
    • With Dave Rabin, MD, PhD
    • Earn 1 CE Credit
    • Learning Objectives:
      At the end of this program, participants will be better able to:
      1. Demonstrate knowledge of administration, subjective effects, and adverse reactions of ketamine, MDMA, and psilocybin.
      2. Analyze and detect barriers to administering potential psychedelic treatments with clients meeting certain diagnostic criteria.
    • Dave Rabin MD, PhD is a board-certified psychiatrist, neuroscientist, entrepreneur, and inventor who has studied resilience and the impact of chronic stress on our lives for over 15 years. At his Apollo Clinic, Dr. Rabin works with clients to empower them to take control of their mental and physical health by tapping into our abilities to adapt and heal ourselves. He is also the co-founder of Apollo Neuroscience, a wearable device for stress and mood regulation, and the executive director of The Board of Medicine, a 501(c)(3) nonprofit organization of world-renowned physicians and scientists establishing evidence-based clinical guidelines for unregulated alternative medicines, including plant medicines.
17. Inbodied Integration: Supporting Clients & Clinicians in Taking Psychedelic Experiences Forward
    • Integration is the name of the game with psychedelic-assisted therapies – and in any enriching experience with a psychoactive medicine. It is essential for any enriching experiences with psychoactive medicine. In order to effectively support others in living the truths that emerge from journeys, every clinician in the field must know the landscape of the medicine that they facilitate, from their own psyche, and know how to make action oriented meaning of what one learns in these spaces.
      In this CE webinar, Lauren engages a creative, integrative approach to leading integration with action-oriented meaning and explore how to creatively approach psychedelic integration sessions in a way that anchors good, encourages clients to actively shift their mindset, and how to shed what's needed in order.
    • With Lauren Taus, LCSW
    • Earn 1 CE Credit
    • Learning Objectives:
      At the end of this program, participants will be better able to:
      1. Explain the importance of whole-bodied integration before, during, and after psychedelic-assisted therapies.
      2. Prepare clients for their journey with legal psychedelic medicines.
    • Lauren Taus, LCSW is a psychedelic-assisted therapist, trained to work with both psychoactive compounds and plant medicines. Lauren leads Inbodied Life, a Psychedelic-Assisted Therapy and Integration training while also running a group practice based in Los Angeles. Lauren is a lifelong student, educator and activist.
18. The Essential Role of Person-Centered Music in Psychedelic Therapy: 10 Years of Research
    • Music plays a critical role in psychedelic therapy.
      
      In psychedelic-assisted therapy, the experience of music can facilitate implicit learning. We look at patient experiences and musical examples used by Dr. Mendel Kaelen and Wavepaths to create immersive sound experiences that facilitate safe, ethical, and effective therapy sessions. Level up the experience with person-centered music in your psychedelic therapy practice.
      
      Explore Wavepaths (10% off with PSPARTNER10).
    • With Mendel Kaelen, PhD
    • Earn 1 CE Credit
19. Psychedelics & Psychotropics: Drug Interaction and Clinical Approach
    • Do you understand how psychedelics and psychiatric medications interact? Several psychedelic substances are in late-stage clinical trials. It’s important for clinicians to understand clinically significant drug interactions.
      
      Here we discuss drug interactions that are likely to significantly influence the safety and efficacy of psychedelic therapies with leading educator, psychopharmacological consultant, and Spirit Pharmacist, Ben Malcolm, PharmD, MPH, BCPP. We take a look at the pharmacokinetics and pharmacodynamics of well-researched psychedelics and common psychiatric medications.
    • With Ben Malcolm, PharmD, MPH, BCPP
    • Earn 1 CE Credit
    • Learning Objectives:
      At the end of this program, participants will be better able to:
      1. Describe the pharmacokinetics and pharmacodynamics of well-researched psychedelics and common psychiatric medications.
      2. Explain interactions between psychedelic substances and other medications that pose safety risks or reduced effects.
    • Ben Malcolm PharmD, MPH, aka The Spirit Pharmacist, earned his Masters in Public Health (MPH) and Doctorate of Pharmacy (PharmD) at Touro University California. After residency training he obtained Board Certification in Psychiatric Pharmacy (BCPP).
      
      Dr. Malcolm's interests focus on the intersection between psychiatric medications and psychedelic therapies. Currently he provides psychopharmacology consulting services for clients and continuing education on psychedelics and psychotropic medications.
20. Starting a Psychedelic Therapy Practice
    • Starting a psychedelic practice can feel overwhelming. As a therapist there are many considerations to be aware of including medical safety, the role of prescribers and therapists, insurance, training, ethics, set and setting, and more.
      
      Here is a discussion about how to get involved with psychedelic therapy as a therapist with Integrative Psychiatry Institute’s Co-Founders Keith Kurlander, MA, LPC and Will Van Derveer, MD. We will explore the the do’s and don’ts, and where to start in the psychedelic therapy space.
    • With:
      • Will van Derveer, MD
      • Keith Kurlander, MA, LPC
    • Earn 1 CE Credit
21. The Legal Landscape of Psychedelic Therapy
    • The psychedelic renaissance, and the legality of these medicines, is rapidly changing. Therapists, clinicians, providers and policymakers must remain conscientious of this fast moving world.
      
      In this webinar, we discuss the current issues surrounding equitable and legal access to psychedelic therapy with Plant Medicine Law Group’s Adriana Kertzer, JD, Hadas Alterman, JD, from APPA, and Harry Nelson, JD, from the largest healthcare and life sciences specialty law firm in Los Angeles. We explore the current legal landscape and discuss how this applies to clinical practice, policy, and research to all become better informed to practice in this emerging psychedelic medicine field.
    • With:
      • Hadas Alterman, JD
      • Adriana Kertzer, JD
      • Harry Nelson, JD
    • Earn 1 CE Credit
    • Learning Objectives:
      At the end of this program, participants will be better able to:
      1. Identify legal and ethical considerations surrounding the recommendation, encouragement and discussion of psychedelic assisted practices as a clinician.
      2. Utilize knowledge within legal boundaries of healthcare and life sciences to bring forth best clinical practice.
2023
22. Prescribing Connection: How Psychedelics Impact Love and Relationships
    • There’s a lot of talk about the loneliness epidemic, but what if the real epidemic lack of social connection?
      
      When was the last time you thought about how your social life, your sex life, your romantic life, and your family life affect your health and happiness? There’s a lot of talk about the loneliness epidemic, but what if the real epidemic lacks social connection? Your social network matters to your health—online and in real life. Ten percent of women have no close friends. Fifteen percent of men have no close friendships at all, a fivefold increase since 1990.
      
      This webinar features a conversation with Molly Maloof, MD, healthspan and wellness expert, and founder of Adamo Biosciences, about the role psychedelics play in enhancing social connection and ethical challenges with using psychoactive substances in couples' therapy. We discuss human relationships, sexuality, love and attachment, healing trauma, and how psychedelics can be important tools for extending healthspan.
    • With Molly Maloof, MD
    • Earn 1 CE Credit
    • Learning Objectives:
      At the end of this program, participants will be better able to:
      1. Describe how social connections impact mental heal.
      2. Explain how lifestyle optimizations can support love and relationships.
      3. Discuss psychedelic research on social connection.
    • Molly Maloof, MD is passionate about extending healthspan through her medical practice, personal brand, entrepreneurial and educational endeavors. She provides personalized medicine to world class entrepreneurs, investors, and executives. Since 2012, she has worked as an advisor or consultant to over 50 companies in the digital health, consumer health, and biotechnology industries. She is the Founder of Adamo, a brand dedicated to optimizing human capacity and connection with consumer health products and educational media.
23. The Need for Anti-Racist Training in Psychedelic Therapy
    • Watch a conversation with Dr. Darron Smith, MAPS-trained therapist, physician’s assistant, educator, and researcher, about anti-racist considerations for psychedelic-assisted therapists (PATs) to practice when holding space for Black, Indigenous, and People of Color.
      
      Here, we discuss how microaggressions and biases continue to inform how white people show up to interact with BIPOC individuals in the emerging field of psychedelic therapy.
    • With Darron Smith, PhD, PA-C, DFAAPA
    • Earn 1 CE Credit
    • Learning Objectives:
      At the end of this program, participants will be better able to:
      1. Describe the differences between race-based concepts such as race, racism, prejudice, and discrimination.
      2. Explain why people of color are needed as psychedelic-assisted therapists and facilitators.
      3. Explain the importance of creating and maintaining a safe container for people of color interested in psychedelic medicine.
      4. Discuss why it is critical that therapists and facilitators who do not look like their clients assess their own biases and prejudices before working with BIPOC.
    • Darron T. Smith, PhD, PA-C, DFAAPA, is a physician assistant and US Army veteran with over twenty years of healthcare-related experience as a PA educator and mental health treatment provider in psychiatry, and he has trained with MAPS’ MDMA-assisted therapy. His research and scholarship examine US-based systems of racial oppression and systemic inequality found in all societal domains, including healthcare, the family (transracial adoption), healthcare disparities, religion, sport, culture, and politics.
24. Holistic Addiction Recovery with Psychedelics & Interdisiplinary Modalities
    • Listen to a conversation about why entheogenic plant medicines such as ayahuasca–when combined with other therapeutic and recovery modalities—can be effective in ways that conventional approaches may not be. We discuss how addiction is a complex condition of body, mind, human relations, and spirit. In the pursuit of reward—the relief of pain, unresolved emotional experiences, and trauma—the elements of nature, nurture, and choice become tragically misaligned.
    • With Celina De Leon, M.Div
    • Earn 1 CE Credit
    • Learning Objectives:
      At the end of this program, participants will be better able to:
      1. Assess alternative approaches to consider addiction.
      2. Critique the definition of 'recovery' by traditional standards.
      3. Describe ways that alternative approaches to addiction recovery may assist in ways that conventional methods do not.
    • Celina De Leon, M.Div is the co-founder of Natura Care Programs and the founder and director of Circle of Sacred Nature 501(c)3 church. She is also a Stanford graduate, a Fulbright scholar, has a Masters in Divinity from the Graduate Theological Union, and has received professional training in spiritual care through the art of chaplaincy. Her training as a ceremony facilitator draws upon 20 years of experience with Amazonian plant medicine and a foundation in yoga, meditation, and Ayurveda. Celina is also a longtime apprentice of Taita Juan Agreda Chindoy of the Kamentsa indigenous community of the Upper Putumayo of Colombia.
25. Psychedelics for Women's Health
    • Interactions between hormones and neurotransmitters affect many aspects of our mental well-being and health. Could psychedelic medicines become a treatment strategy for women's health issues? Join Psychedelic Support co-founder and neuropharmacologist Dr. Allison Feduccia, PhD, for a presentation on the science of hormones and neurotransmitters, health challenges across the life cycle, and why psychedelic medicines could become treatment options for premenstrual symptoms, sexual health, postpartum depression, menopause, and end-of-life care. Learn about the research behind these advances and takeaways for women who are searching healing through psychedelic medicine.
    • With Allison Feduccia, PhD
    • Earn 1 CE Credit
    • Learning Objectives:
      At the end of this program, participants will be better able to:
      1. Describe how hormones and neurotransmitters interact to affect women’s mental health.
      2. Discuss the research on psychedelics for women's health issues, including neurobiological mechanisms and psychedelic therapy.
    • Allison Feduccia, PhD, is a neuropharmacologist, psychedelic researcher and educator. She is the Co-founder of Psychedelic Support, a platform for education and connection to psychedelic practitioners, and Project New Day, a 501(c)3 nonprofit on a mission to help people overcome addiction and actualize mental health through the responsible use of psychedelics. She began researching MDMA in 2004, accumulating 20 years of experience in mental health research at UT Austin, UCSF, NIH, and MAPS. Currently, she is working on a psilocybin clinical trial for palliative care.
26. Family Matters in Psychedelic Therapy
    • Family members and/or close others represent an often-untapped resource for enhancing change in individuals engaged in psychedelic psychotherapy. Providing a supportive other with an active role in the healing process can also decrease their feelings of anxiety, powerlessness, and even paralysis states that can contribute to systemic difficulties, especially as the healing work disrupts old patterns.
      
      Clinical psychologist and psychedelic research scientist Adele Lafrance, PhD, gives a presentation on the ethical, neurobiological and psychological considerations for supporting others’ involvement in psychedelic-assisted healing. Learn about the psychedelic research that illustrates how other-engagement can facilitate powerful shared experiences and leverage opportunities to heal and grow in the context of one’s closest relationships, the most fertile ground of all.
    • With Adele Lafrance, PhD
    • Earn 1 CE Credit
    • Learning Objectives:
      At the end of this program, participants will be better able to:
      1. List rationales for supportive-other involvement in psychedelic therapy.
      2. Describe strategies to protect systemic disruptions secondary to psychedelic healing.
    • Dr. Adele Lafrance is a clinical psychologist, research scientist, author and developer of emotion-focused treatment modalities. She is active in the research and practice of psychedelic medicine, with a focus on ayahuasca, MDMA, psilocybin and ketamine. Adele has a particular interest in mechanisms and models of healing, including emotion processing, spirituality, love, and family-based psychedelic medicine.
27. Training in Psychedelic-Assisted Therapy with IPI
    • Are you interested in becoming a certified provider of psychedelic-assisted therapy?
      
      As a clinician, there are many considerations to be aware of before enrolling in a psychedelic training program.
      
      Join us for a discussion about psychedelic training opportunities with Integrative Psychiatry Institute’s Co-Founders Keith Kurlander, MA, LPC, and Will Van Derveer, MD. We explore the curriculum of the year-long online program offered by IPI and answer your questions about how to apply this training to your clinical practice.
    • With:
      • Keith Kurlander, MA, LPC
      • Will Van Derveer, MD
    • Earn 1 CE Credit
28. Q&A with Psychedelic Therapy Legal Experts
    • The legal landscape of psychedelic therapies has been evolving rapidly. As scientific evidence grows, governments are reevaluating their policies, aiming to strike a balance between patient safety and expanding the potential benefits of psychedelic-assisted therapies.
      
      Listen to a Q&A about the current issues around legal access to psychedelic therapy with Adriana Kertzer, JD, Deborah Linden Saly, JD, and Harry Nelson, JD. These expert attorneys discuss navigating legal challenges around plant medicines and how to become better informed to practice in this emerging psychedelic medicine field.
    • With:
      • Adriana Kertzer, JD
      • Deborah Linden Saly, JD
      • Harry Nelson, JD
    • Earn 1 CE Credit
29. EMBARK Psychedelic Therapy: A New Approach for the Whole Person
    • EMBARK Psychedelic Therapy for Depression: A New Approach for the Whole Person is a comprehensive guidebook for clinicians that presents a novel therapeutic framework for administering psychedelic medicines. The EMBARK model was developed in response to the growing interest in psychedelic medicines for treating mental health disorders, particularly depression, and the identified gaps in existing models of psychedelic-assisted therapy (PAT).
      
      Join Dr. Alex Belser, PhD, and learn about the model’s six Clinical Domains and therapeutic change mechanisms for depression treatment.
    • With Alex Belser, PhD
    • Earn 1 CE Credit
30. Truth Medicine: A Nondual Approach to Psychedelic Psychotherapy
    • Discovering, accessing, and applying love toward one’s self is the essence of the nondual approach to psychedelic psychotherapy. In this approach, we start from this place of innocence, ease, and peace and work our way through the layers of trauma, shame, and untended grief with love as the healing balm.
      
      Join Michael Sapiro, PsyD, as he walks us through this approach.
    • With Michael Sapiro, PsyD
    • Earn 1 CE Credit
31. The Remedy Ecosystem: From Research to Practice with Psychedelics
    • Join Dr Anne Wagner to explore Remedy Institute’s sustainable program for psychedelic research and practice. They conduct clinical trials with MDMA to treat PTSD in individuals and couples. Dr. Wagner discusses Remedy’s ecosystem model, studies, and the promise of relationally-based healing with psychedelics in this webinar.
      
      Listen to this conversation with Dr. Anne Wagner and Psychedelic Support.
    • With Anne Wagner, C.Psych
    • Earn 1 CE Credit
32. Inflammation, Food, and Mood
    • Hippocrates said, “Leave your drugs in the chemist’s pot if you can heal the patient with food.” This includes psychedelics! While often seen as a universal remedy for mood issues, psychedelics have limited effectiveness. Recognizing the complexity of mental health, we explore the causes of psychological problems and how nutrition can deeply and sustainably address them. Research suggests combining psychedelics with other healing methods for optimal results.
      
      Join Erica Zelfand, ND, to discover how food can enhance mental health and psychedelic medicine outcomes.
    • With Erica Zelfand, ND
    • Earn 1 CE Credit
33. Art for Access: A Psychedelic Integration Model
    • Embark on a transformative journey into the heart of psychedelic integration with Psychedelic Support and Jennifer Allen, LMFT, ATR-BC. The integration model Jennifer has developed, Art for Access, comes out of her work with dreams, shamanic drum journeys, and her art therapy background. By accessing a potent aspect of the expanded state/journey as a portal, the drum journey allows the process to unfold further, and image-making acts as a bridge to ordinary consciousness.
      
      Jump into this FREE experiential webinar on Art for Access.
    • With Jennifer Allen, LMFT, ATR-BC
    • Earn 1 CE Credit
34. The Global Psychedelic Survey: Primary Outcomes
    • Explore the latest insights into global psychedelic use with esteemed researcher Philippe Lucas, PhD, and Psychedelic Support. Leading a survey with 6,379 participants, Philippe unveiled key trends, showcasing psilocybin as the most used psychedelic (75.3%). Fueled by “personal growth” (85.1%) and “general well-being” (68.7%), the survey reveals 60% engaging in therapeutic use, offering valuable insights for public health, substance use, and psychedelic-related policy development.
      
      Watch this FREE, concise, and insightful exploration of naturalistic psychedelic experiences with global implications.
    • With Philippe Lucas, PhD
    • Earn 1 CE Credit
35. IPI Psychedelic Assisted Therapy: Provider Training Overview
    • Discover the ins and outs of IPI’s Psychedelic-Assisted Therapy Training Program with Jaime R. Davila, LPC, and Drew Snyder, MS, LPC
      
      Explore the program’s structure, requirements, and comprehensive curriculum covering psilocybin, ketamine, and MDMA therapies. Gain insights into the training format, including lectures, group discussions, and hands-on psilocybin and ketamine practicum experiences. Plus, find out how this training can pave the way for eligibility as a licensed psilocybin services facilitator in Oregon.
    • With:
      • Jaime R. Davila, LPC
      • Drew Snyder, MS, LPC
    • Earn 1 CE Credit
36. How MDMA Heals or Harms: The Basic Science
    • MDMA may become an approved medicine in the United States this year. Yet science is still working to understand the mechanisms of its therapeutic effects and its side effects.
      
      Join Matthew Baggott, PhD, and Psychedelic Support to review studies in healthy volunteers, animals, and cells that shed light on these mechanisms, including new data on novel molecules that seem to retain MDMA’s core therapeutic effects while potentially decreasing side effects.
    • With Matthew Baggott, PhD
    • Earn 1 CE Credit
37. Psychedelics Past and Present: Global Perspectives
    • As psychedelic substances enjoy a resurgence in clinical and popular discussions, their once-maligned reputation is changing. Popular books, documentaries, and social media tout the benefits of psychedelics, while clinical studies report breakthroughs in mental health treatments.
      
      This enlightening presentation with Erika Dyck, PhD, takes us on a journey through the history of psychedelic studies, highlighting the highs and lows that have led to this renaissance moment and examining the methods and approaches that have been celebrated or demonized along the way.
    • With Erika Dyck, PhD
    • Earn 1 CE Credit
38. Balancing the Inner-Directive & Directive Approach in Psychedelic Sessions
    • The Inner-Directive model is foundational in many psychedelic-assisted protocols, emphasizing the “intrinsic healing” of the client’s psyche, also known as the “Inner Healing Intelligence” by Stan Grof. While this model is key to protocols like the MAPS MDMA therapy manual, there may be times to include more Directive approaches.
      
      Join Kyle Buller, MS, and Michael Sapiro, PsyD, as they review the Inner-Directive approach, compare it with directive frameworks, and present a new model with case study examples.
    • With:
      • Kyle Buller, MS
      • Michael Sapiro, PsyD
    • Earn 1 CE Credit
39. Balancing the Inner-Directive & Directive Approach in Psychedelic Sessions
    • Psychedelics are showing promise beyond mental health, offering potential relief for chronic pain and neurodegeneration.
      
      Join Psychedelic Support and Court Wing, founder of REMAP Therapeutics and co-founder of the Psychedelics & Pain Association, to explore how psychedelics can address tough physical conditions like neuropathic pain and fibromyalgia. Discover key research, case studies, and best practices for using psychedelics in pain management.
    • With Court Wing
    • Earn 1 CE Credit
40. MDMA-Assisted Group Therapy for PTSD
    • MDMA-assisted group therapy, developed in the 1970s, has evolved with unique characteristics compared to other psychedelic group models.
      
      Join Psychedelic Support and Chris Stauffer, MD, for an insightful discussion on the evolution of MDMA-Assisted Group Therapy for PTSD. Dr. Stauffer compares early practices with current protocols, explores how MDMA influences group dynamics and discusses how this model could expand access to therapy once approved.
    • With Chris Stauffer, MD
    • Earn 1 CE Credit